Could a common heart pill help those with artificial valves?
NCT ID NCT07192341
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 33 times
Summary
This study is testing whether a drug called sacubitril/valsartan can improve heart function in people who have an artificial heart valve and heart failure with reduced pumping ability. About 220 adults will take the drug and be monitored for at least one grade improvement in their heart failure symptoms. The goal is to see if this medication offers a new way to manage heart failure in this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kafrelsheikh University
RECRUITINGKafr ash Shaykh, Kafrelsheikh, 33516, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.